Our focus is on estrogen signaling for several reasons, including endogenous activation of ER by estrogen in endometrial cancer cells, ER activation through estrogen signaling is a key oncogenic event in endometrial cancer (Rodriguez et al. 2019), and ER is a well-studied transcription factor, which provides a strong foundation for interpretation of results. Here, ESR1 is linked to endometrial cancer.